CAPRICOR THERAPEUTICS, INC. Proceeds from Issuance of Private Placement
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Proceeds from Issuance of Private Placement of $31.17 million for the 98-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2013-11-14
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2013-09-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2013-03-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2012-12-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2012 was $1.19M, a 48.05% decline from fiscal 2011.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2011 was $2.30M, a 49.11% decline from fiscal 2010.
- CAPRICOR THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2010 was $4.52M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month | Proceeds from Issuance of Private Placement 71 month | Proceeds from Issuance of Private Placement 74 month | Proceeds from Issuance of Private Placement 77 month | Proceeds from Issuance of Private Placement 80 month | Proceeds from Issuance of Private Placement 83 month | Proceeds from Issuance of Private Placement 86 month | Proceeds from Issuance of Private Placement 89 month | Proceeds from Issuance of Private Placement 92 month | Proceeds from Issuance of Private Placement 95 month | Proceeds from Issuance of Private Placement 98 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2013-11-14 | $31.17M 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-08-14 | $0.00 derived: sum of 4 quarters · filed 2013-11-14 | $31.17M 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-06-21 | $0.00 derived: sum of 3 quarters · filed 2013-11-14 | $1.19M derived: sum of 4 quarters · filed 2013-11-14 | $31.17M 10-Q · filed 2013-06-21 | |||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $1.19M derived: sum of 3 quarters · filed 2013-11-14 | $1.19M 10-K · filed 2013-06-21 | $31.17M 10-K · filed 2013-06-21 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.19M derived: sum of 2 quarters · filed 2013-11-14 | $1.19M 10-Q · filed 2013-11-14 | $1.19M derived: sum of 4 quarters · filed 2013-11-14 | $31.17M 10-Q · filed 2013-06-21 | |||||||||
| 2012-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.19M 10-Q · filed 2013-08-14 | $1.19M derived: sum of 3 quarters · filed 2013-08-14 | $1.19M derived: sum of 4 quarters · filed 2013-08-14 | $31.17M 10-Q/A · filed 2012-09-10 | |||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-06-21 | $0.00 derived: sum of 3 quarters · filed 2013-06-21 | $29.98M 10-Q/A · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-06-21 | $2.30M 10-K · filed 2013-06-21 | $29.98M 10-K · filed 2012-04-02 | ||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-06-21 | $2.30M 10-Q · filed 2013-06-21 | $29.98M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $2.30M 10-Q/A · filed 2012-09-10 | $29.98M 10-Q · filed 2011-08-15 | ||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02 | $0.00 derived: sum of 2 quarters · filed 2012-04-02 | $4.52M 10-K · filed 2012-04-02 | |||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $4.52M 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $4.52M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |